Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation

Molecular Oncology

Volumn 6, Issue 4, 2012, Pages 445-457

  Han, Zhong Bo ^a   Zhong, Lin ^a   Teng, Mu Jian ^b   Fan, Jun Wei ^a   Tang, Hua Mei ^a   Wu, Jun Yi ^a   Chen, Hong Yuan ^a   Wang, Zhao Wen ^a   Qiu, Guo Qiang ^a   Peng, Zhi Hai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Liver transplantation; MicroRNA; Prognosis; Recurrence

Indexed keywords

MICRORNA;

ADULT; ARTICLE; BIOINFORMATICS; CANCER PROGNOSIS; CANCER RECURRENCE; DISEASE COURSE; DOWN REGULATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION;

EID: 84864302000     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.04.001     Document Type: Article

References (36)

1. Anglicheau D., Sharma V.K., Ding R., Hummel A., Snopkowski C., Dadhania D., Seshan S.V., Suthanthiran M. MicroRNA expression profiles predictive of human renal allograft status. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5330-5335.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Befeler A.S., Hayashi P.H., Bisceglie A.M.D. Liver transplantation for hepatocellular carcinoma. Gastroenterology-Orlando 2005, 128:1752-1764.
4. Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., Liu C.G., Bhatt D., Taccioli C., Croce C.M. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901-1908.
5. Boeri M., Verri C., Conte D., Roz L., Modena P., Facchinetti F., Calabrò E., Croce C.M., Pastorino U., Sozzi G. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3713-3718.
6. Budhu A., Jia H.L., Forgues M., Liu C.G., Goldstein D., Lam A., Zanetti K.A., Ye Q.H., Qin L.X., Croce C.M. Identification of metastasis related microRNAs in hepatocellular carcinoma. Hepatology 2008, 47:897-907.
7. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
8. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 2005, 353:1793-1801.
9. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., Barbisin M., Xu N.L., Mahuvakar V.R., Andersen M.R. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33:e179.
10. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
11. Guo C., Sah J.F., Beard L., Willson J.K.V., Markowitz S.D., Guda K. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008, 47:939-946.
12. Han K., Tzimas G.N., Barkun J.S., Metrakos P., Tchervenkov J.I., Hilzenrat N., Wong P., Deschênes M. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can. J. Gastroenterol. 2007, 21:39-45.
13. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
14. Jiang J., Lee E.J., Gusev Y., Schmittgen T.D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res. 2005, 33:5394-5403.
15. Lal A., Navarro F., Maher C.A., Maliszewski L.E., Yan N., O'Day E., Chowdhury D., Dykxhoorn D.M., Tsai P., Hofmann O. miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol. Cell 2009, 35:610-625.
16. Li J.H., Xiao X., Zhang Y.N., Wang Y.M., Feng L.M., Wu Y.M., Zhang Y.X. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol. Oncol. 2011, 120:145-151.
17. Li X., Zhang Y., Ding J., Wu K., Fan D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut 2010, 59:579-585.
18. Lossos I.S., Czerwinski D.K., Alizadeh A.A., Wechser M.A., Tibshirani R., Botstein D., Levy R. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 2004, 350:1828-1837.
19. Mazzaferro V., Chun Y.S., Poon R.T.P., Schwartz M.E., Yao F.Y., Marsh J.W., Bhoori S., Lee S.G. Liver transplantation for hepatocellular carcinoma. Ann. Surg. Oncol. 2008, 15:1001-1007.
20. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996, 334:693-700.
21. Pan H.W., Ou Y.H., Peng S.Y., Liu S.H., Lai P.L., Lee P.H., Sheu J.C., Chen C.L., Hsu H.C. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 2003, 98:119-127.
22. Pezzolesi M.G., Platzer P., Waite K.A., Eng C. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am. J. Hum. Genet. 2008, 82:1141-1149.
23. Shen W.F., Hu Y.L., Uttarwar L., Passegue E., Largman C. MicroRNA-126 regulates HOXA9 by binding to the homeobox. Mol. Cell Biol. 2008, 28:4609-4619.
24. Sieghart W., Wang X., Schmid K., Pinter M., König F., Bodingbauer M., Wrba F., Rasoul-Rockenschaub S., Peck-Radosavljevic M. Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria. J. Hepatol. 2011, 54:89-97.
25. Strong R.W. Transplantation for liver and biliary cancer. Semin. Surg. Oncol. 2000, 19:189-199.
26. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2257-2261.
27. Wong Q.W.L., Lung R.W.M., Law P.T.Y., Lai P.B.S., Chan K.Y.Y., To K.F., Wong N. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 2008, 135:257-269.
28. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
29. Yao F., Xiao L., Bass N., Kerlan R., Ascher N., Roberts J. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am. J. Transplant. 2007, 7:2587-2596.
30. Yao F.Y., Ferrell L., Bass N.M., Watson J.J., Bacchetti P., Venook A., Ascher N.L., Roberts J.P. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33:1394-1403.
31. Ye Q.H., Qin L.X., Forgues M., He P., Kim J.W., Peng A.C., Simon R., Li Y., Robles A.I., Chen Y. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med. 2003, 9:416-423.
32. Zavaglia C., De Carlis L., Alberti A.B., Minola E., Belli L.S., Slim A.O., Airoldi A., Giacomoni A., Rondinara G., Tinelli C. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am. J. Gastroenterol. 2005, 100:2708-2716.
33. Zhang J., Du Y., Lin Y., Chen Y., Yang L., Wang H., Ma D. The cell growth suppressor, mir-126, targets IRS-1. Biochem. Biophys. Res. Commun. 2008, 377:136-140.
34. Zheng S.S., Xu X., Wu J., Chen J., Wang W.L., Zhang M., Liang T.B., Wu L.M. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008, 85:1726-1732.
35. Zhou J., Yu L., Gao X., Hu J., Wang J., Dai Z., Wang J.F., Zhang Z., Lu S., Huang X. Plasma MicroRNA Panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J. Clin. Oncol. 2011, 29:4781-4788.
36. Zimmerman M.A., Ghobrial R.M., Tong M.J., Hiatt J.R., Cameron A.M., Hong J., Busuttil R.W. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch. Surg. 2008, 143:182-188.